Resurrection Biology
De-Extinction (Mammoth, Dodo, Thylacine)
3 companies · 1 sourced backers · 16 milestones on record
Resurrection biology uses biotechnology to pursue de-extinction, including animals with key traits of mammoths, dodos and thylacines. Companies also aim to make sequencing, biobanking, cloning and gene editing practical conservation tools, helping preserve genetic diversity, support threatened species and prevent current extinctions.
Where the 3 companies stand today, from their profiles and 10-year milestones. Tap a phase to see who is there.
- ▸Producing living animals with extinct species’ key traits
- ▸Making cloning a routine service
- ▸Reintroducing genetic diversity from cryopreserved cells
- ▸Turning biotechnology into practical wildlife conservation tools
- ›Every sourced story on all frontiers, filterable by company and news type
- ›10-year milestone records for each company: demo vs shipped
- ›Explained: plain-words readiness diagrams for real breakthroughs
- ›Signal Trends of 39 frontiers covering 378 companies over time.
- ›The events calendar: launches, approvals and deadlines ahead
- Colossal Biosciences
Colossal's stated end goal is to produce living animals that carry the key traits of extinct species (starting with a mammoth-like animal) and to use its gen…
Lab · backed by Thomas Tull
- Revive & Restore
To make biotechnology a practical part of wildlife conservation.
Lab
- ViaGen Pets & Equine
ViaGen aims to make cloning a routine, purchasable service for pet and horse owners, and to supply the laboratory capability that lets conservation programme…
Some users
Keep following breakthroughs like these. Every Monday, get up to 5 major breakthroughs and launches explained in plain English.
Free. No account needed. One email a week. Unsubscribe anytime.